IL15-transpresenting WT1-targeted Dendritic Cell Vaccine(Antwerp University Hospital)

N/A

Report date: 2023/07/28 20:00:50

Base Information

Drug NameIL15-transpresenting WT1-targeted Dendritic Cell Vaccine(Antwerp University Hospital)
Drug Alias NameIL15 vaccineIL15Ra vaccineWT1 DC vaccineIL15-transpresenting WT1-targeting DC vaccine
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsInterleukin-15 stimulants
TargetsInterleukin-15
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAntwerp University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesAntwerp University Hospital
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A